Results 261 to 270 of about 171,941 (345)

Nanobiomechanics in Oncology: Atomic Force Microscopy for Cancer Mechanophenotyping Using Cellular Young's Modulus

Journal of the Royal Society of New Zealand, Volume 57, Issue 1, February 2027.
This review examines the current literature on the application of atomic force microscopy (AFM) to cancer mechanophenotyping, with particular emphasis on cellular Young's modulus and its potential diagnostic significance. A structured electronic search of PubMed, Scopus and Google Scholar was conducted to identify studies published between 1999 and ...
Hermawan Tjoa, Li Mei, Harsha De Silva, Darryl Tong, Guangzhao Guan   +4 more
wiley   +1 more source

Osteosarcoma as a second or later malignancy: Presentation, treatment, and survival of 198 patients from the Cooperative Osteosarcoma Study Group

Alexandru Anton Sabo, Stefanie Hecker‐Nolting, Stefan Bielack, Matthias Kevric, Benjamin Sorg, Mihnea Paul Dragomir, Thekla v. Kalle, Leo Kager, Michaela Nathrath, Claudia Rössig, Florian Babor, Reinhard Windhager, Judith S. Hecker, Christoph K.W. Deinzer, Peter Reichardt, Markus Metzler, Martin Benesch, Gerda Hofmann-Wackersreuther, Martin Ebinger, Claudia Blattmann   +19 more
openalex   +1 more source

Adaptive Decision-Level Fusion for Osteosarcoma Classification Using Unpaired X-Ray and Histopathology Data. [PDF]

J Imaging
Fouad Z, Saad S, M Mahmoud A, M Salem AB.   +3 more
europepmc   +1 more source

Asymptomatic Cardiotoxicity After High‐Dose Anthracycline Treatment in Sarcoma Patients Assessed by Biomarkers and Echocardiography

International Journal of Cancer, Volume 159, Issue 11, Page 2755-2765, 1 December 2026.
ABSTRACT Treatment of sarcoma includes high‐dose anthracyclines, which can cause cardiotoxicity. This study assesses the correlation of cardiac biomarkers and echocardiographic parameters on asymptomatic cardiotoxicity in sarcoma patients treated with anthracyclines.
Elissa A. S. Polomski, Frank M. Speetjens, J. Wouter Jukema, Julius C. Heemelaar, Michiel A. J. van de Sande, Hans Gelderblom, M. Louisa Antoni   +6 more
wiley   +1 more source

GD2 Induction by Combination Chromatin-Directed Inhibitors Enhances Targeting of Ewing Sarcoma and Osteosarcoma by CAR T Cells

Justin R. Sperlazza, Kevin P. Field, Caitlyn McComb, Elisa Landoni, Sara K. Peterson, Anna Jin, Austin J. Hepperla, Rachel L. Chambers, William C. Zamboni, Barbara Savoldo, Ian J. Davis   +10 more
openalex   +1 more source

Statement of Retraction: MicroRNA-744-5p suppresses tumorigenesis and metastasis of osteosarcoma through the p38 mitogen-activated protein kinases pathway by targeting transforming growth factor-beta 1. [PDF]

Bioengineered
europepmc   +1 more source

Expression of Concern: MicroRNA-93 promotes the tumorigenesis of osteosarcoma by targeting TIMP2. [PDF]

Biosci Rep
Zhang H, Zhang J, Meng F, Zhu H, Yan H, Guo Y, Zhang S.   +6 more
europepmc   +1 more source

DNA Methylation and Transcriptomic Profiles of Wilms Tumour Reveal New Deregulated Genes and Epigenetic Processes Relevant for Tumour Stratification and Management

International Journal of Cancer, Volume 159, Issue 11, Page 2736-2754, 1 December 2026.
ABSTRACT Wilms Tumour (WT), the most common kidney cancer in children, presents features of altered kidney development and frequently exhibits molecular alterations at the 11p15.5 imprinted locus, affecting the IGF2 and H19 genes, which contribute to tumour growth and predisposition.
Abu Saadat, Francesco Cecere, Federica Rossetti, Laura Pignata, Emilia D'Angelo, Carlo Giaccari, Gaetano Verde, Paola Quarello, Franca Fagioli, Josep Roma, Manel Esteller, Enrique de Álava, Flavia Cerrato, Andrea Riccio, Angela Sparago   +14 more
wiley   +1 more source

Rothmund-Thomson Syndrome Diagnosed during Osteosarcoma Workup in a Child with Biallelic RECQL4 Variants: A Case Report

Soo Kyung Lee, Yun Young Choi, Anna Cho, Y. Kim, Yeon Jung Lim, Hyoung Soo Choi   +5 more
openalex   +2 more sources

Statement of Retraction: S100 calcium-binding protein A10 contributes to malignant traits in osteosarcoma cells by regulating glycolytic metabolism via the AKT/mTOR pathway. [PDF]

Bioengineered
europepmc   +1 more source